Cargando…

Drug Repurposing for Influenza Virus Polymerase Acidic (PA) Endonuclease Inhibitor

Drug repurposing can quickly and effectively identify novel drug repurposing opportunities. The PA endonuclease catalytic site has recently become regarded as an attractive target for the screening of anti-influenza drugs. PA N-terminal (PA(N)) inhibitor can inhibit the entire PA endonuclease activi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meng, Xin, Wang, Ye
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8659148/ https://www.ncbi.nlm.nih.gov/pubmed/34885905 http://dx.doi.org/10.3390/molecules26237326

Ejemplares similares

A novel small-molecule inhibitor of influenza A virus acts by suppressing PA endonuclease activity of the viral polymerase
por: Yuan, Shuofeng, et al.
Publicado: (2016)

Structural and Biochemical Basis for Development of Influenza Virus Inhibitors Targeting the PA Endonuclease
por: DuBois, Rebecca M., et al.
Publicado: (2012)

N-acylhydrazone inhibitors of influenza virus PA endonuclease with versatile metal binding modes
por: Carcelli, Mauro, et al.
Publicado: (2016)

Functional properties of the novel PA-X endonuclease of human influenza virus
por: Bavagnoli, Laura, et al.
Publicado: (2014)

An anti-influenza A virus microbial metabolite acts by degrading viral endonuclease PA
por: Zhao, Jianyuan, et al.
Publicado: (2022)

Identification of the I38T PA Substitution as a Resistance Marker for Next-Generation Influenza Virus Endonuclease Inhibitors
por: Jones, Jeremy C., et al.
Publicado: (2018)

PA-E18G substitution in influenza A virus confers resistance to ZX-7101, a cap-dependent endonuclease inhibitor
por: Luo, Dan, et al.
Publicado: (2023)

HDAC6 Restricts Influenza A Virus by Deacetylation of the RNA Polymerase PA Subunit
por: Chen, Huan, et al.
Publicado: (2019)

Author Correction: An anti-influenza A virus microbial metabolite acts by degrading viral endonuclease PA
por: Zhao, Jianyuan, et al.
Publicado: (2023)

Biochemical characterization of recombinant influenza A polymerase heterotrimer complex: Endonuclease activity and evaluation of inhibitors
por: Xing, Weimei, et al.
Publicado: (2017)

Identification of Influenza PA(N) Endonuclease Inhibitors via 3D-QSAR Modeling and Docking-Based Virtual Screening
por: Zhang, Chao, et al.
Publicado: (2021)

The novel influenza A virus protein PA-X and its naturally deleted variant show different enzymatic properties in comparison to the viral endonuclease PA
por: Bavagnoli, Laura, et al.
Publicado: (2015)

The PA Subunit of the Influenza Virus Polymerase Complex Affects Replication and Airborne Transmission of the H9N2 Subtype Avian Influenza Virus
por: Hao, Mengchan, et al.
Publicado: (2019)

A novel compound to overcome influenza drug resistance in endonuclease inhibitors
por: Ren, Yixin, et al.
Publicado: (2023)

Author Correction for Jones et al., “Identification of the I38T PA Substitution as a Resistance Marker for Next-Generation Influenza Virus Endonuclease Inhibitors”
por: Jones, Jeremy C., et al.
Publicado: (2018)

Anthralin Suppresses the Proliferation of Influenza Virus by Inhibiting the Cap-Binding and Endonuclease Activity of Viral RNA Polymerase
por: Hu, Ao, et al.
Publicado: (2020)

Fragment-Based Identification of Influenza Endonuclease Inhibitors
por: Credille, Cy V., et al.
Publicado: (2016)

Identification of influenza polymerase inhibitors targeting C-terminal domain of PA through surface plasmon resonance screening
por: Lo, Chun-Yeung, et al.
Publicado: (2018)

Characterization of influenza virus variants induced by treatment with the endonuclease inhibitor baloxavir marboxil
por: Omoto, Shinya, et al.
Publicado: (2018)

I-60 Structural study of RNA polymerase PA subunit from an avian influenza virus
por: Liu, Y.F.
Publicado: (2008)

Susceptibility of Influenza Viruses to the Novel Cap-Dependent Endonuclease Inhibitor Baloxavir Marboxil
por: Takashita, Emi, et al.
Publicado: (2018)

Carboxylic Acid Isostere Derivatives of Hydroxypyridinones as Core Scaffolds for Influenza Endonuclease Inhibitors
por: Stokes, Ryjul W., et al.
Publicado: (2022)

Mutational Analyses of the Influenza A Virus Polymerase Subunit PA Reveal Distinct Functions Related and Unrelated to RNA Polymerase Activity
por: Liang, Yuhong, et al.
Publicado: (2012)

Correction to Fragment-Based Identification of Influenza Endonuclease Inhibitors
por: Credille, Cy V., et al.
Publicado: (2017)

Influenza virus polymerase inhibitors in clinical development
por: Hayden, Frederick G., et al.
Publicado: (2019)

Conserved Endonuclease Function of Hantavirus L Polymerase
por: Rothenberger, Sylvia, et al.
Publicado: (2016)

Structural Analysis of Specific Metal Chelating Inhibitor Binding to the Endonuclease Domain of Influenza pH1N1 (2009) Polymerase
por: Kowalinski, Eva, et al.
Publicado: (2012)

Artificial Hybrids of Influenza A Virus RNA Polymerase Reveal PA Subunit Modulates Its Thermal Sensitivity
por: Kashiwagi, Takahito, et al.
Publicado: (2010)

Phosphorylation of the PA subunit of influenza polymerase at Y393 prevents binding of the 5′-termini of RNA and polymerase function
por: Liu, Lu, et al.
Publicado: (2023)

Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2018–2020
por: Govorkova, Elena A., et al.
Publicado: (2022)

The Surface-Exposed PA(51-72)-Loop of the Influenza A Virus Polymerase Is Required for Viral Genome Replication
por: Nilsson-Payant, Benjamin E., et al.
Publicado: (2018)

Protein-Structure Assisted Optimization of 4,5-Dihydroxypyrimidine-6-Carboxamide Inhibitors of Influenza Virus Endonuclease
por: Beylkin, Diane, et al.
Publicado: (2017)

Selective Degradation of Host RNA Polymerase II Transcripts by Influenza A Virus PA-X Host Shutoff Protein
por: Khaperskyy, Denys A., et al.
Publicado: (2016)

In Silico Drug Repurposing of FDA-Approved Drugs Highlighting Promacta as a Potential Inhibitor of H7N9 Influenza Virus
por: Mtambo, Sphamandla E., et al.
Publicado: (2022)

Drug Repurposing for Japanese Encephalitis Virus Infection by Systems Biology Methods
por: Lv, Bo-Min, et al.
Publicado: (2018)

Truncation of C-terminal 20 amino acids in PA-X contributes to adaptation of swine influenza virus in pigs
por: Xu, Guanlong, et al.
Publicado: (2016)

Repurposing of Drugs as Novel Influenza Inhibitors From Clinical Gene Expression Infection Signatures
por: Pizzorno, Andrés, et al.
Publicado: (2019)

Repurposing antiviral drugs against the human monkeypox virus DNA-dependent RNA polymerase; in silico perspective
por: Abduljalil, Jameel M., et al.
Publicado: (2022)

Pharmacophore-Model-Based Drug Repurposing for the Identification of the Potential Inhibitors Targeting the Allosteric Site in Dengue Virus NS5 RNA-Dependent RNA Polymerase
por: Kumar, Sanjay, et al.
Publicado: (2022)

Toosendanin From Melia Fructus Suppresses Influenza A Virus Infection by Altering Nuclear Localization of Viral Polymerase PA Protein
por: Jin, Young-Hee, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_b5i1nknaogt34mt4413m66vglk